Semi-Annual Consolidated Statement Of Cash Flows

Renascience Inc. - Filing #7319611

Concept As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-228,586,000 JPY
-283,462,000 JPY
Income taxes paid
-1,957,000 JPY
-1,205,000 JPY
Net cash provided by (used in) operating activities
-230,519,000 JPY
-284,641,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,577,000 JPY
-2,225,000 JPY
Net cash provided by (used in) investing activities
-1,567,000 JPY
232,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
46,500,000 JPY
110,371,000 JPY
Net cash provided by (used in) financing activities
46,500,000 JPY
110,371,000 JPY
Net increase (decrease) in cash and cash equivalents
-185,586,000 JPY
-174,036,000 JPY
Cash and cash equivalents
1,646,193,000 JPY
1,831,780,000 JPY
2,005,816,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.